The prognostic value of the pretreatment serum CA 125, squamous cell carcinoma antigen
(SCC), and carcinoembryonic antigen (CEA) levels in relation to tumor type, vascular …

SUMMARY Between 1978 and 1987, 439 patients with primary cervical carcinoma were
admitted to our department. Seventy-seven patients (17.5%) had cervical adenocarcinoma …

Objective: The purpose of this study was to determine the prognostic significance of a
pretreatment serum CA 125 value in patients who were diagnosed with adenocarcinoma of …

In the present study we evaluated the clinical usefulness of the tumor antigens, squamous
cell carcinoma antigen (SCC) and ovarian carcinoma antigen (CA 125), in populations of …

Serum levels of carcinoembryonic antigen (CEA) and cancer antigens CA 125 and CA 19.9
were determined by immunoradiometric assay in 96 patients diagnosed of invasive …

Serum levels of squamous cell carcinoma antigen SCC, carcinoembryonic antigen CA 125,
and tissue polypeptide antigen were determined in 142 patients with primary cervical …

We evaluated 104 patients with newly diagnosed carcinoma of the cervix. Pre-and post-
therapy and followup CA-125 levels were measured in 64 patients. Fifty-five patients (86%) …

A review is given of the clinical use and interpretation of serum tumor marker levels during
the treatment of patients with cancer of the uterine cervix. Pretreatment serum squamous cell …

A study was made of the prognostic value of measurements of pretreatment serum marker
levels in patients with carcinoma of the uterine cervix undergoing radiotherapy. The markers …

Ninety-one patients with adenocarcinoma of the cervix had 4 tumour markers (TMs) assayed
before treatment. Serum squamous cell carcinoma antigen (SCC)(n= 91) was raised in 25%; …